Potential role of anti-interleukin-17 in COVID-19 treatment

Dermatol Ther. 2020 Jul;33(4):e13715. doi: 10.1111/dth.13715. Epub 2020 Jun 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Humans
  • Interleukin-17 / antagonists & inhibitors*
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2

Substances

  • IL17A protein, human
  • Interleukin-17